Maze Therapeutics Announces Profitable IPO Filing
Maze Therapeutics reveals a profit in its IPO filing, planning to list on Nasdaq under 'MAZE'. Discover more about this promising biotech company's financial prospects.
Maze Therapeutics revealed a profit in its IPO filing and plans to list on Nasdaq under the symbol 'MAZE'.